Maternal Anti-Ro Antibody Titers Obtained with Commercially Available Immunoassays are Strongly Associated with Immune-Mediated Fetal Heart Disease.

Edgar Jaeggi,Vathany Kulasingam, Jack Chen,Chun-Po Steve Fan,Carl Laskin,Robert M Hamilton,Linda T Hiraki,Earl D Silverman,Lusia Sepiashvili

Arthritis & rheumatology (Hoboken, N.J.)（2023）

引用 1|浏览13

暂无评分

摘要

CNL is associated with substantially higher anti-Ro antibody titers than are obtained with a standard CIA. Enhancing the assay measuring range allows an improved specificity of identifying at-risk pregnancies of CNL. This article is protected by copyright. All rights reserved.

查看译文

关键词

antibody,commercially available immunoassays

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要